Douglas Lane & Associates’s Sanofi SNY Stock Holding History

Douglas Lane & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,405	Closed	-$336K	–	204
2018 Q2	$336K	Sell	8,405 -10,811	-56%	-$426K	0.01%	173
2018 Q1	$770K	Sell	19,216 -12,391	-39%	-$516K	0.02%	150
2017 Q4	$1.36M	Sell	31,607 -17,315	-35%	-$798K	0.03%	134
2017 Q3	$2.44M	Sell	48,922 -26,995	-36%	-$1.31M	0.06%	119
2017 Q2	$3.64M	Sell	75,917 -19,858	-21%	-$949K	0.09%	120
2017 Q1	$4.33M	Sell	95,775 -55,485	-37%	-$2.35M	0.11%	121
2016 Q4	$6.12M	Sell	151,260 -65,569	-30%	-$2.58M	0.16%	111
2016 Q3	$8.28M	Sell	216,829 -85,930	-28%	-$3.45M	0.22%	102
2016 Q2	$12.7M	Sell	302,759 -31,770	-9%	-$1.3M	0.36%	92
2016 Q1	$13.4M	Buy	+334,529	New	+$13.4M	0.37%	91

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Douglas Lane & Associates's SNY Position: Q3 2018 in Review

Douglas Lane & Associates sold out of Sanofi (SNY) in Q3 2018, closing a stake of 8,405 shares — an estimated $336K sold.

Douglas Lane & Associates first reported a position in SNY in Q1 2016 and held it in 10 quarters. The position peaked at $13.4M in Q1 2016. 480 funds tracked by Wall St. Rank hold SNY as of Q3 2018.

Douglas Lane & Associates reported no remaining Sanofi position as of Q3 2018 after selling out during the quarter.
Douglas Lane & Associates sold 8,405 Sanofi shares in Q3 2018, an estimated $336K.
Douglas Lane & Associates first reported a position in Sanofi in Q1 2016 and held it in 10 quarters.
Douglas Lane & Associates's Sanofi position peaked at $13.4M in Q1 2016.
480 funds tracked by Wall St. Rank held Sanofi as of Q3 2018.

Based on Douglas Lane & Associates's 13F filing for Q3 2018, filed 9 Oct 2018.